EP2462957A3 - Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux - Google Patents
Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux Download PDFInfo
- Publication number
- EP2462957A3 EP2462957A3 EP11190599A EP11190599A EP2462957A3 EP 2462957 A3 EP2462957 A3 EP 2462957A3 EP 11190599 A EP11190599 A EP 11190599A EP 11190599 A EP11190599 A EP 11190599A EP 2462957 A3 EP2462957 A3 EP 2462957A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- hemostasis
- treatment
- methods
- osseous defects
- putty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000007547 defect Effects 0.000 title 1
- 230000023597 hemostasis Effects 0.000 title 1
- 239000007943 implant Substances 0.000 title 1
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000004067 bulking agent Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 230000002439 hemostatic effect Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002138 osteoinductive effect Effects 0.000 abstract 1
- 238000011477 surgical intervention Methods 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0042—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50497803P | 2003-09-23 | 2003-09-23 | |
PCT/US2004/026738 WO2005034726A2 (fr) | 2003-09-23 | 2004-09-16 | Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux |
EP04781435.5A EP1677664B1 (fr) | 2003-09-23 | 2004-09-16 | Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux |
Related Parent Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04781435.5A Division-Into EP1677664B1 (fr) | 2003-09-23 | 2004-09-16 | Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux |
EP04781435.5A Division EP1677664B1 (fr) | 2003-09-23 | 2004-09-16 | Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux |
EP04781435.5 Division | 2004-09-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2462957A2 EP2462957A2 (fr) | 2012-06-13 |
EP2462957A3 true EP2462957A3 (fr) | 2012-09-19 |
EP2462957B1 EP2462957B1 (fr) | 2019-04-24 |
Family
ID=34434873
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04781435.5A Active EP1677664B1 (fr) | 2003-09-23 | 2004-09-16 | Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux |
EP11190599.8A Active EP2462957B1 (fr) | 2003-09-23 | 2004-09-16 | Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux |
EP11190604A Withdrawn EP2462958A3 (fr) | 2003-09-23 | 2004-09-16 | Implants absorbables et leurs procédés d'utilisation pour une hémostase et pour traiter des défauts osseux |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04781435.5A Active EP1677664B1 (fr) | 2003-09-23 | 2004-09-16 | Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11190604A Withdrawn EP2462958A3 (fr) | 2003-09-23 | 2004-09-16 | Implants absorbables et leurs procédés d'utilisation pour une hémostase et pour traiter des défauts osseux |
Country Status (10)
Country | Link |
---|---|
US (3) | US8105628B2 (fr) |
EP (3) | EP1677664B1 (fr) |
JP (2) | JP5031367B2 (fr) |
KR (1) | KR101100045B1 (fr) |
CN (2) | CN101052360B (fr) |
AU (2) | AU2004279319B2 (fr) |
CA (2) | CA2539568C (fr) |
HK (1) | HK1116388A1 (fr) |
NZ (1) | NZ545521A (fr) |
WO (1) | WO2005034726A2 (fr) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030228288A1 (en) | 1999-10-15 | 2003-12-11 | Scarborough Nelson L. | Volume maintaining osteoinductive/osteoconductive compositions |
US9387094B2 (en) * | 2000-07-19 | 2016-07-12 | Warsaw Orthopedic, Inc. | Osteoimplant and method of making same |
US7323193B2 (en) * | 2001-12-14 | 2008-01-29 | Osteotech, Inc. | Method of making demineralized bone particles |
US7163691B2 (en) * | 2001-10-12 | 2007-01-16 | Osteotech, Inc. | Bone graft |
AU2004247143B2 (en) | 2003-06-11 | 2010-09-23 | Warsaw Orthopedic, Inc. | Osteoimplants and methods for their manufacture |
CA2539568C (fr) * | 2003-09-23 | 2013-09-10 | Orthotherapeutics, Llc | Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux |
WO2005034816A1 (fr) | 2003-09-23 | 2005-04-21 | Ortho Therapeutics, Llc. | Implants hemostatiques bioabsorbables de type mastic |
US7955616B2 (en) * | 2003-09-23 | 2011-06-07 | Orthocon, Inc. | Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
EP1781264B1 (fr) | 2004-08-04 | 2013-07-24 | Evonik Corporation | Procede de production de systemes d'administration, et systemes d'administration |
US8603528B2 (en) * | 2004-09-16 | 2013-12-10 | Abyrx, Inc. | Compositions and method for the reduction of post-operative pain |
US7993578B2 (en) * | 2004-10-29 | 2011-08-09 | Depuy Spine, Inc. | Methods and kits for aseptic filling of products |
US20060216230A1 (en) * | 2005-03-28 | 2006-09-28 | The Regents Of The University Of California | Radioactive bone cement for treatment of tumors in bone |
US9326995B2 (en) * | 2005-04-04 | 2016-05-03 | The Regents Of The University Of California | Oxides for wound healing and body repair |
MX2007012231A (es) | 2005-04-04 | 2007-12-07 | Univ California | Materiales inorganicos para modulacion hemostatica y curacion terapeutica de heridas. |
DE202005009755U1 (de) * | 2005-06-21 | 2005-09-08 | Cervitech, Inc. | Halter für Zwischenwirbelprothesen |
CN101484145A (zh) * | 2005-07-25 | 2009-07-15 | 奥索康公司 | 用于减轻手术后疼痛的组合物和方法 |
WO2007056671A1 (fr) * | 2005-11-02 | 2007-05-18 | Osteotech, Inc. | Greffe osseuse hemostatique |
US20080031914A1 (en) * | 2006-08-02 | 2008-02-07 | Drapeau Susan J | Flowable biomaterial composition |
DE102006060958A1 (de) * | 2006-12-20 | 2008-06-26 | Jennissen, Herbert P., Prof. Dr. | Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung |
DE102007051914A1 (de) * | 2007-10-29 | 2009-05-07 | Herbert Prof. Dr. Jennissen | Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel |
US8124601B2 (en) * | 2007-11-21 | 2012-02-28 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
EP2222281B1 (fr) | 2007-12-20 | 2018-12-05 | Evonik Corporation | Procédé pour préparer des microparticules ayant un faible volume de solvant résiduel |
US9492375B2 (en) * | 2008-07-23 | 2016-11-15 | Warsaw Orthopedic, Inc. | Foam carrier for bone grafting |
US8039433B2 (en) * | 2008-08-19 | 2011-10-18 | Warsaw Orthopedic, Inc. | Osteogenic compositions containing a coloring agent |
CA2742047A1 (fr) * | 2008-10-24 | 2010-04-29 | Warsaw Orthopedic, Inc. | Compositions et procedes pour favoriser la formation osseuse |
BR112012006443A2 (pt) * | 2009-09-22 | 2017-07-25 | Evonik Degussa Corp | dispositivos de implante que apresentam configurações de cargas variáveis de agentes bioativos |
US8173154B2 (en) * | 2010-01-06 | 2012-05-08 | The Curators Of The University Of Missouri | Boron trioxide glass-based fibers and particles in dressings, sutures, surgical glue, and other wound care compositions |
BRPI1000625A2 (pt) * | 2010-03-09 | 2011-11-01 | Agal Consultoria E Assessoria Ltda | polìmero reabsorvìvel, colorido e radiopaco utilizado na fabricação de dispositivos cirúrgicos implantáveis |
US9968446B2 (en) | 2011-03-23 | 2018-05-15 | The Regents Of The University Of California | Tubular scaffold for fabrication of heart valves |
PL2626092T3 (pl) * | 2011-04-01 | 2016-02-29 | Zhuhai Ortus Biotechnology Co Ltd | Medyczny wchłanialny hemostatyczny materiał do ran z obnażeniem kości i sposób jego wytwarzania |
DE102011016277B4 (de) | 2011-04-06 | 2013-02-21 | Heraeus Medical Gmbh | Plastisch verformbares, biodegradierbares Hämostyptikum und Verfahren zum Formen eines solchen |
WO2012170700A2 (fr) | 2011-06-07 | 2012-12-13 | Orthocon, Inc. | Applicateur avec embout adaptable |
WO2013053755A2 (fr) | 2011-10-11 | 2013-04-18 | Baxter International Inc. | Compositions hémostatiques |
WO2013067154A1 (fr) * | 2011-11-01 | 2013-05-10 | Orthocon, Inc. | Compositions et procédés pour hémostase |
CN104394888A (zh) | 2012-05-30 | 2015-03-04 | 克洛克斯科技公司 | 用于生物光子骨重建的组合物和方法 |
CN102886075B (zh) * | 2012-09-19 | 2015-01-14 | 中南大学 | 人体硬组织修复材料及其制备方法 |
DE102013211316A1 (de) * | 2013-06-17 | 2014-12-18 | Aesculap Ag | Hämostyptikum |
US9895465B2 (en) * | 2014-03-12 | 2018-02-20 | Pioneer Surgical Technology, Inc. | Absorbable compositions and methods for their use in hemostasis |
CN104383594B (zh) * | 2014-11-10 | 2016-06-29 | 青岛橡胶谷知识产权有限公司 | 一种聚丁烯琥珀酸酯/羟基磷灰石复合生物陶瓷材料的制备方法 |
CN104353119A (zh) * | 2014-11-10 | 2015-02-18 | 苏州蔻美新材料有限公司 | 一种聚羟基乙酸/羟基磷灰石复合生物陶瓷材料的制备方法 |
CN106215225B (zh) * | 2016-07-26 | 2021-02-12 | 韦淑玲 | 一种医用的骨创面止血材料及其制备方法 |
CN106110395B (zh) * | 2016-08-18 | 2022-08-02 | 陕西东望科技有限公司 | 一种具有自修复、抗菌功效的骨修复支架及其制作方法 |
CN107261207B (zh) * | 2017-06-28 | 2020-11-24 | 广州益诚生物科技有限公司 | 一种胶原蛋白凝胶及其制备方法 |
CN107519528B (zh) * | 2017-08-30 | 2020-10-23 | 山东省立医院 | 一种生物可吸收的骨蜡及其制备方法 |
US9919080B1 (en) * | 2017-10-27 | 2018-03-20 | Tyrx, Inc. | Kits for local delivery of water soluble agents and methods of use |
CN108187128B (zh) * | 2018-02-07 | 2021-08-31 | 广州迈普再生医学科技股份有限公司 | 一种可吸收的止血骨蜡及其制备方法 |
CN108295305B (zh) * | 2018-03-21 | 2021-09-28 | 苏州澳森匹科医疗科技股份有限公司 | 一种骨填充材料及其制备方法 |
IL262716A (en) * | 2018-11-01 | 2018-11-29 | Omrix Biopharmaceuticals Ltd | Oxidized cellulose preparations |
KR20210132054A (ko) | 2019-01-31 | 2021-11-03 | 셀 메디신 가부시키가이샤 | 무기 염류 단백 복합 의료 기기 |
CN111714684A (zh) * | 2019-03-19 | 2020-09-29 | 广东博与再生医学有限公司 | 一种骨止血材料及其制备方法 |
CN111714687A (zh) * | 2019-03-19 | 2020-09-29 | 广东博与再生医学有限公司 | 一种骨止血材料及其制备方法 |
CN111714688A (zh) * | 2019-03-19 | 2020-09-29 | 广东博与再生医学有限公司 | 一种骨止血材料及其制备方法 |
CN111714686A (zh) * | 2019-03-19 | 2020-09-29 | 广东博与再生医学有限公司 | 一种骨止血材料及其制备方法 |
CN111714697A (zh) * | 2019-03-19 | 2020-09-29 | 广东博与再生医学有限公司 | 促进新骨形成的骨止血材料及其制备方法 |
CN112138203B (zh) * | 2019-06-26 | 2022-11-08 | 陕西佰傲再生医学有限公司 | 骨止血材料 |
CN112138205A (zh) * | 2019-06-26 | 2020-12-29 | 广东博与再生医学有限公司 | 骨止血材料 |
CN112138206A (zh) * | 2019-06-26 | 2020-12-29 | 广东博与再生医学有限公司 | 骨止血材料 |
CN111184911A (zh) * | 2020-02-21 | 2020-05-22 | 陕西佰傲再生医学有限公司 | 一种口腔止血及修复材料及其制备方法 |
CN111647176B (zh) * | 2020-05-27 | 2022-12-06 | 浙江理工大学 | 一种丝胶蛋白微球的制备方法 |
CN111729125B (zh) * | 2020-07-31 | 2022-10-04 | 陕西佰傲再生医学有限公司 | 骨止血材料 |
CN112190770B (zh) * | 2020-09-30 | 2022-08-05 | 诺一迈尔(山东)医学科技有限公司 | 可降解拔牙创填充组合物及其制备方法和应用 |
CN113769152B (zh) * | 2021-06-30 | 2022-08-16 | 南方医科大学 | 一种复合胶黏剂及其制备方法和应用 |
CN113750289B (zh) * | 2021-10-20 | 2022-11-29 | 香港大学深圳医院 | 基于磷酸钙的有机-无机复合生物活性材料及其制备方法 |
CN115814146B (zh) * | 2022-11-01 | 2023-12-22 | 山东大学 | 一种仿生凝血机制的止血粉制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439420A (en) * | 1982-11-16 | 1984-03-27 | Ethicon, Inc. | Absorbable hemostatic composition |
US4568536A (en) * | 1985-02-08 | 1986-02-04 | Ethicon, Inc. | Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition |
US5681873A (en) * | 1993-10-14 | 1997-10-28 | Atrix Laboratories, Inc. | Biodegradable polymeric composition |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2611706A (en) * | 1949-12-21 | 1952-09-23 | Wyeth Corp | Fat composition for infants' food |
US2642375A (en) * | 1951-08-21 | 1953-06-16 | Ethicon Suture Lab Inc | Hemostatic compositions |
US2772999A (en) * | 1952-06-06 | 1956-12-04 | Johnson & Johnson | Hemostatic surgical compositions and dressings |
US2773000A (en) * | 1952-06-06 | 1956-12-04 | Johnson & Johnson | Hemostatic surgical dressings |
US3109562A (en) * | 1954-09-07 | 1963-11-05 | Schering Corp | Nozzle perforating cap for collapsible tubes |
US3924000A (en) | 1971-02-08 | 1975-12-02 | Geraldine H Thiele | Injectable solution |
US4186448A (en) | 1976-04-16 | 1980-02-05 | Brekke John H | Device and method for treating and healing a newly created bone void |
GB1584080A (en) | 1977-12-05 | 1981-02-04 | Ethicon Inc | Absorbable hemostatic composition |
FR2532546B1 (fr) * | 1982-09-07 | 1985-12-27 | Biotrol Sa Lab | Pate pour la protection de la peau |
US4443430A (en) | 1982-11-16 | 1984-04-17 | Ethicon, Inc. | Synthetic absorbable hemostatic agent |
DE3245956A1 (de) | 1982-12-11 | 1984-06-14 | Beiersdorf Ag, 2000 Hamburg | Chirurgisches material |
US4612923A (en) | 1983-12-01 | 1986-09-23 | Ethicon, Inc. | Glass-filled, absorbable surgical devices |
US4650665A (en) | 1985-02-08 | 1987-03-17 | Ethicon, Inc. | Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition |
US4770803A (en) | 1986-07-03 | 1988-09-13 | The Lubrizol Corporation | Aqueous compositions containing carboxylic salts |
US5047166A (en) | 1987-03-10 | 1991-09-10 | Lever Brothers Company, Division Of Conopco, Inc. | Skin treatment composition containing monoester of citric acid |
DE3825211A1 (de) | 1988-07-25 | 1990-02-01 | Henkel Kgaa | Verbesserte koerperresorbierbare knochenwachse (iii) |
US5290558A (en) * | 1989-09-21 | 1994-03-01 | Osteotech, Inc. | Flowable demineralized bone powder composition and its use in bone repair |
US5073373A (en) | 1989-09-21 | 1991-12-17 | Osteotech, Inc. | Flowable demineralized bone powder composition and its use in bone repair |
US5108403A (en) * | 1990-11-09 | 1992-04-28 | Stern Mark S | Bone waxing device |
US5454787A (en) * | 1991-02-15 | 1995-10-03 | Lundquist; Ingemar H. | Torquable tubular assembly and torquable catheter utilizing the same |
CA2108038A1 (fr) | 1991-06-05 | 1992-12-06 | Kelly J. Brodbeck | Composition de blanchiment a sec a dispersibilite amelioree |
US5356629A (en) * | 1991-07-12 | 1994-10-18 | United States Surgical Corporation | Composition for effecting bone repair |
AU2605592A (en) | 1991-10-15 | 1993-04-22 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
WO1993010163A2 (fr) * | 1991-11-12 | 1993-05-27 | Nepera, Inc. | Hydrogels adhesifs presentant une vie utile prolongee et procede de preparation |
WO1993009783A1 (fr) | 1991-11-15 | 1993-05-27 | Ss Pharmaceutical Co., Ltd. | Emplatre anti-inflammatoire et analgesique |
US5314476A (en) | 1992-02-04 | 1994-05-24 | Osteotech, Inc. | Demineralized bone particles and flowable osteogenic composition containing same |
US5502092A (en) | 1994-02-18 | 1996-03-26 | Minnesota Mining And Manufacturing Company | Biocompatible porous matrix of bioabsorbable material |
US6197320B1 (en) | 1994-03-11 | 2001-03-06 | Shalaby W. Shalaby | Absorbable E-caprolactone polymers and medical devices |
DE69635301T2 (de) * | 1995-03-24 | 2006-07-20 | Genzyme Corp., Cambridge | Verminderung von adhäsionen durch gesteuerte verabreichung von aktivsauerstoffinhibitoren |
US6413539B1 (en) | 1996-10-31 | 2002-07-02 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
US5730967A (en) * | 1995-06-05 | 1998-03-24 | Whitehill Oral Technologies, Inc. | Ultramulsion based skin care compositions |
AU698281B2 (en) | 1995-06-07 | 1998-10-29 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
US5641502A (en) | 1995-06-07 | 1997-06-24 | United States Surgical Corporation | Biodegradable moldable surgical material |
DE19547356A1 (de) | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung |
ATE223472T1 (de) | 1996-03-15 | 2002-09-15 | Amway Corp | Verfahren zur herstellung eines freifliessenden agglomerisierten niotensidhaltigen waschmittels |
DE19613685C1 (de) * | 1996-04-05 | 1997-09-11 | Herberts Gmbh | Säurefreie Katalysatorpaste, deren Herstellung und Verwendung bei der kathodischen Elektrotauchlackierung |
US5696101A (en) * | 1996-04-16 | 1997-12-09 | Eastman Chemical Company | Oxidized cellulose and vitamin E blend for topical hemostatic applications |
US6139872A (en) * | 1996-08-14 | 2000-10-31 | Henkel Corporation | Method of producing a vitamin product |
US6117444A (en) | 1997-04-10 | 2000-09-12 | Brigham & Women's Hospital | Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent |
ZA987019B (en) * | 1997-08-06 | 1999-06-04 | Focal Inc | Hemostatic tissue sealants |
US6992057B2 (en) | 2000-02-22 | 2006-01-31 | The Procter & Gamble Company | Fatty acids, soaps, surfactant systems, and consumer products based thereon |
US20020076429A1 (en) * | 1998-01-28 | 2002-06-20 | John F. Wironen | Bone paste subjected to irradiative and thermal treatment |
US6437018B1 (en) | 1998-02-27 | 2002-08-20 | Musculoskeletal Transplant Foundation | Malleable paste with high molecular weight buffered carrier for filling bone defects |
US6030635A (en) | 1998-02-27 | 2000-02-29 | Musculoskeletal Transplant Foundation | Malleable paste for filling bone defects |
JP3114016B2 (ja) * | 1998-05-15 | 2000-12-04 | 株式会社ホギメディカル | 細胞接着促進効果を有する創傷止血材 |
US6454787B1 (en) | 1998-12-11 | 2002-09-24 | C. R. Bard, Inc. | Collagen hemostatic foam |
DE19858891A1 (de) | 1998-12-19 | 2000-06-21 | Merck Patent Gmbh | Verbesserte Knochensiegel |
US6642285B1 (en) * | 1999-02-02 | 2003-11-04 | Robert Mathys Stiftung | Implant comprising calcium cement and hydrophobic liquid |
MXPA01009653A (es) * | 1999-03-25 | 2002-05-14 | 3M Innovative Properties Co | Composicion de recubrimiento anti-picadura. |
US20020048551A1 (en) * | 1999-04-06 | 2002-04-25 | Keller Brian C. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US6461631B1 (en) | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
US20020102301A1 (en) * | 2000-01-13 | 2002-08-01 | Joseph Schwarz | Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof |
AU2001245346A1 (en) * | 2000-06-28 | 2002-01-08 | Atul J. Shukla | Biodegradable vehicles and delivery systems of biologically active substances |
US6576249B1 (en) | 2000-11-13 | 2003-06-10 | El Gendler | Bone putty and method |
WO2002045686A2 (fr) * | 2000-12-07 | 2002-06-13 | Altana Pharma Ag | Preparation pharmaceutique en pate comprenant un ingredient actif labile en milieu acide |
US20040018238A1 (en) | 2001-02-26 | 2004-01-29 | Shukla Atul J | Biodegradable vehicles and delivery systems of biolgically active substances |
AU2002350088A1 (en) * | 2001-06-22 | 2003-01-08 | Millard Marsden Mershon | Compositions and methods for reducing blood and fluid loss from open wounds |
JP4490095B2 (ja) | 2001-06-29 | 2010-06-23 | メドグラフト マイクロテック インコーポレイテッド | 生体分解性の注入可能な移植物およびそれに関連する製造方法ならびに使用方法 |
US6565884B2 (en) | 2001-09-10 | 2003-05-20 | Interpore Cross International | Bone graft material incorporating demineralized bone matrix and lipids |
US7112587B2 (en) | 2001-09-21 | 2006-09-26 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
US20030093114A1 (en) * | 2001-11-13 | 2003-05-15 | Melvin Levinson | Method for effecting hemostasis |
US6960346B2 (en) | 2002-05-09 | 2005-11-01 | University Of Tennessee Research Foundation | Vehicles for delivery of biologically active substances |
US20040109893A1 (en) | 2002-06-25 | 2004-06-10 | Guohua Chen | Sustained release dosage forms of anesthetics for pain management |
US7927626B2 (en) * | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
CA2539568C (fr) * | 2003-09-23 | 2013-09-10 | Orthotherapeutics, Llc | Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux |
US7955616B2 (en) | 2003-09-23 | 2011-06-07 | Orthocon, Inc. | Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
WO2005034816A1 (fr) | 2003-09-23 | 2005-04-21 | Ortho Therapeutics, Llc. | Implants hemostatiques bioabsorbables de type mastic |
US8603528B2 (en) | 2004-09-16 | 2013-12-10 | Abyrx, Inc. | Compositions and method for the reduction of post-operative pain |
CN101484145A (zh) | 2005-07-25 | 2009-07-15 | 奥索康公司 | 用于减轻手术后疼痛的组合物和方法 |
-
2004
- 2004-09-16 CA CA2539568A patent/CA2539568C/fr not_active Expired - Fee Related
- 2004-09-16 EP EP04781435.5A patent/EP1677664B1/fr active Active
- 2004-09-16 CN CN2004800275475A patent/CN101052360B/zh active Active
- 2004-09-16 JP JP2006527998A patent/JP5031367B2/ja active Active
- 2004-09-16 KR KR1020067007535A patent/KR101100045B1/ko active IP Right Grant
- 2004-09-16 CA CA2824210A patent/CA2824210A1/fr not_active Abandoned
- 2004-09-16 NZ NZ545521A patent/NZ545521A/en unknown
- 2004-09-16 EP EP11190599.8A patent/EP2462957B1/fr active Active
- 2004-09-16 US US10/941,890 patent/US8105628B2/en active Active
- 2004-09-16 CN CN2012100550233A patent/CN102579162A/zh active Pending
- 2004-09-16 EP EP11190604A patent/EP2462958A3/fr not_active Withdrawn
- 2004-09-16 WO PCT/US2004/026738 patent/WO2005034726A2/fr active Application Filing
- 2004-09-16 AU AU2004279319A patent/AU2004279319B2/en not_active Ceased
-
2008
- 2008-03-05 HK HK08102525.2A patent/HK1116388A1/xx not_active IP Right Cessation
-
2011
- 2011-02-04 AU AU2011200502A patent/AU2011200502B2/en not_active Ceased
- 2011-09-01 US US13/223,611 patent/US20120027817A1/en not_active Abandoned
-
2012
- 2012-01-12 JP JP2012004202A patent/JP2012115682A/ja active Pending
- 2012-03-02 US US13/410,995 patent/US20120189671A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439420A (en) * | 1982-11-16 | 1984-03-27 | Ethicon, Inc. | Absorbable hemostatic composition |
US4568536A (en) * | 1985-02-08 | 1986-02-04 | Ethicon, Inc. | Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition |
US5681873A (en) * | 1993-10-14 | 1997-10-28 | Atrix Laboratories, Inc. | Biodegradable polymeric composition |
Also Published As
Publication number | Publication date |
---|---|
CA2539568A1 (fr) | 2005-04-21 |
AU2004279319A1 (en) | 2005-04-21 |
EP1677664B1 (fr) | 2014-07-30 |
US20120189671A1 (en) | 2012-07-26 |
CN101052360B (zh) | 2012-05-16 |
CA2539568C (fr) | 2013-09-10 |
EP1677664A2 (fr) | 2006-07-12 |
AU2011200502A1 (en) | 2011-03-03 |
EP2462957A2 (fr) | 2012-06-13 |
EP2462958A2 (fr) | 2012-06-13 |
NZ545521A (en) | 2010-02-26 |
WO2005034726A2 (fr) | 2005-04-21 |
CN101052360A (zh) | 2007-10-10 |
HK1116388A1 (en) | 2008-12-24 |
JP2012115682A (ja) | 2012-06-21 |
US8105628B2 (en) | 2012-01-31 |
US20120027817A1 (en) | 2012-02-02 |
EP2462958A3 (fr) | 2012-09-19 |
CA2824210A1 (fr) | 2005-04-21 |
WO2005034726A3 (fr) | 2007-05-03 |
CN102579162A (zh) | 2012-07-18 |
KR101100045B1 (ko) | 2011-12-29 |
JP5031367B2 (ja) | 2012-09-19 |
US20050065214A1 (en) | 2005-03-24 |
AU2004279319B2 (en) | 2010-11-04 |
EP1677664A4 (fr) | 2009-08-19 |
JP2007515196A (ja) | 2007-06-14 |
AU2011200502B2 (en) | 2014-02-27 |
EP2462957B1 (fr) | 2019-04-24 |
KR20060080228A (ko) | 2006-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2462957A3 (fr) | Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux | |
Cortese et al. | Platelet-rich fibrin (PRF) in implant dentistry in combination with new bone regenerative technique in elderly patients | |
Kuemmerle et al. | Assessment of the suitability of a new brushite calcium phosphate cement for cranioplasty–an experimental study in sheep | |
Kumar et al. | Comparison between silk sutures and cyanoacrylate adhesive in human mucosa-a clinical and histological study | |
Bozo et al. | World’s first clinical case of gene-activated bone substitute application | |
Wittwer et al. | Complications after zygoma fracture fixation: is there a difference between biodegradable materials and how do they compare with titanium osteosynthesis? | |
Zhou et al. | Translation of bone wax and its substitutes: History, clinical status and future directions | |
Stockmann et al. | Resorbable versus titanium osteosynthesis devices in bilateral sagittal split ramus osteotomy of the mandible–the results of a two centre randomised clinical study with an eight-year follow-up | |
WO2008019128A3 (fr) | Pansement solide pour le traitement de lésion tissulaire | |
JP2007515196A5 (fr) | ||
MX2007003099A (es) | Composicion de bio-material de propositos multiples. | |
Tanuma et al. | Comparison of bone regeneration between octacalcium phosphate/collagen composite and β-tricalcium phosphate in canine calvarial defect | |
US8303971B2 (en) | Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation | |
Hooley et al. | The effect of polylactic acid granules on the incidence of alveolar osteitis after mandibular third molar surgery: A prospective randomized study | |
Singh et al. | The effect of alloplastic bone graft and absorbable gelatin sponge in prevention of periodontal defects on the distal aspect of mandibular second molars, after surgical removal of impacted mandibular third molar: a comparative prospective study | |
Kazancıoğlu et al. | The effectiveness of a new hemostatic agent (Ankaferd Blood Stopper) for the control of bleeding following tooth extraction in hemophilia: a controlled clinical trial | |
Lye et al. | The use of demineralized bone matrix for grafting during Le Fort I and chin osteotomies: techniques and complications | |
Spence et al. | Bone formation in a carbonate-substituted hydroxyapatite implant is inhibited by zoledronate: the importance of bioresorption to osteoconduction | |
Lopez-Heredia et al. | Processing and in vivo evaluation of multiphasic calcium phosphate cements with dual tricalcium phosphate phases | |
de Oliveira et al. | Effects of fibrin sealant and bone fragments on defect regeneration performed on rat tibiae: An experimental study | |
CN112138203B (zh) | 骨止血材料 | |
CN105031747B (zh) | 一种可吸收拔牙创护理组合物及其制备方法与应用 | |
Pereira et al. | Injectable hydrogels as a delivery system for bone regeneration | |
CN111714697A (zh) | 促进新骨形成的骨止血材料及其制备方法 | |
Fahmy et al. | Materials Used Intraoperatively During Oral and Maxillofacial Surgery Procedures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 1677664 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61L 24/00 20060101ALI20120816BHEP Ipc: A61K 31/19 20060101ALI20120816BHEP Ipc: A61L 27/54 20060101AFI20120816BHEP |
|
17P | Request for examination filed |
Effective date: 20130319 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20161202 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602004053922 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61L0027540000 Ipc: A61L0024080000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/19 20060101ALI20181005BHEP Ipc: A61L 24/00 20060101ALI20181005BHEP Ipc: A61L 24/08 20060101AFI20181005BHEP |
|
INTG | Intention to grant announced |
Effective date: 20181031 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ABYRX, INC. |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAR | Information related to intention to grant a patent recorded |
Free format text: ORIGINAL CODE: EPIDOSNIGR71 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
INTC | Intention to grant announced (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20190313 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 1677664 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1123356 Country of ref document: AT Kind code of ref document: T Effective date: 20190515 Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602004053922 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20190424 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190824 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190725 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190724 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1123356 Country of ref document: AT Kind code of ref document: T Effective date: 20190424 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602004053922 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 |
|
26N | No opposition filed |
Effective date: 20200127 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190916 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190930 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190930 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190916 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190424 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20040916 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230513 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230920 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230928 Year of fee payment: 20 Ref country code: DE Payment date: 20230920 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230927 Year of fee payment: 20 |